Simultaneous bilateral subtrochanteric fractures following risedronate therapy

Journal of Orthopaedic Science

Volumn 16, Issue 4, 2011, Pages 467-470

  Ovaska, Mikko T ^a   Mäkinen, Tatu J ^a   Madanat, Rami ^a  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADALIMUMAB; AMINO TERMINAL TELOPEPTIDE; CALCIUM; NALTREXONE; PREDNISOLONE; PREDNISONE; RISEDRONIC ACID; VITAMIN D;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BONE DENSITY; BONE RADIOGRAPHY; BONE TURNOVER; CASE REPORT; CLINICAL FEATURE; COMMINUTED FRACTURE; DISEASE DURATION; ENZYME BLOOD LEVEL; FEMALE; FEMUR SUBTROCHANTERIC FRACTURE; FRACTURE REDUCTION; HIP PAIN; HUMAN; INTRAMEDULLARY NAILING; LONG TERM CARE; LUMBAR SPINE; OSTEOPENIA; OSTEOSYNTHESIS; STRESS FRACTURE; TREATMENT DURATION;

EID: 80052456190     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-011-0058-y     Document Type: Article

References (21)

1. DM Black AV Schwartz KE Ensrud JA Cauley S Levis SA Quandt S Satterfield RB Wallace DC Bauer L Palermo LE Wehren A Lombardi AC Santora SR Cummings 2006 Effects of continuing or stopping aledronate after 5 years of treatment: the Fracture Intervention Trail Long-term Extension (FLEX): a randomized trail JAMA 296 2927 2938 17190893 10.1001/jama.296.24.2927 1:CAS:528:DC%2BD2sXnvVGh (Pubitemid 46021497)
2. T Mashiba CH Turner T Hirano MR Forwood CC Johnston DB Burr 2001 Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone 28 524 531 11344052 10.1016/S8756-3282(01)00414-8 1:CAS:528:DC%2BD3MXjtlChsLk%3D (Pubitemid 32416465)
3. CV Odvina JE Zerwekh DS Rao N Maalouf FA Gottschalk CYC Pak 2005 Severely suppressed bone turnover: a potential complication of alendronate therapy J Clin Endocrinol Metab 90 1294 1301 15598694 10.1210/jc.2004-0952 1:CAS:528:DC%2BD2MXisVOhsr0%3D (Pubitemid 40463979)
4. CM Capeci NC Tejwani 2009 Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy J Bone Joint Surg Am 91 2556 2561 19884427 10.2106/JBJS.H.01774
5. K Cermak F Shumelinsky J Alexiou MJ Gebhart 2010 Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy Clin Orthop Relat Res 468 1991 1996 20020334 10.1007/s11999-009-1192-0
6. SK Goh KY Yang JS Koh MK Wong SY Chua DT Chua TS Howe 2007 Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution J Bone Joint Surg Br 89 349 353 17356148 10.1302/0301-620X.89B3.18146 (Pubitemid 46563912)
7. EB Kwek SK Goh JS Koh MA Png TS Howe 2008 An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39 224 231 18222447 10.1016/j.injury.2007.08.036
8. BA Lenart AS Neviaser S Lyman CC Chang F Edobar-Osula B Steele MC van der Meulen DG Lorich JM Lane 2009 Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study Osteoporosis Int 20 1353 1362 10.1007/s00198-008-0805-x 1:CAS:528:DC%2BD1MXotlyhurY%3D
9. AS Neviaser JM Lane BA Lenart F Edobor-Osula DG Lorich 2008 Low-energy femoral shaft fractures associated with alendronate use J Orthop Trauma 22 346 350 18448990 10.1097/BOT.0b013e318172841c (Pubitemid 351630250)
10. AS Sayed-Noor GO Sjöden 2008 Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy-a case report Acta Orthop 79 565 567 18766492 10.1080/17453670710015580
11. AS Sayed-Noor GO Sjöden 2009 Case reports: two femoral insufficiency fractures after long-term alendronate therapy Clin Orthop Relat Res 467 1921 1926 19198962 10.1007/s11999-009-0725-x
12. DM Black MP Kelly HK Genant L Palermo R Eastell C Bucci-Rechtweg J Cayley PC Leung S Boonen A Santora A de Papp DC Bauer 2010 The fracture intervention trial and HORIZON pivotal fracture trail streering committee N Engl J Med 362 1761 1771 20335571 10.1056/NEJMoa1001086 1:CAS:528:DC%2BC3cXmtVSrsr4%3D
13. E Shane 2010 Evolving data about subtrochanteric fractures and bisphosphonates N Engl J Med 362 1825 1827 20335574 10.1056/NEJMe1003064 1:CAS:528:DC%2BC3cXmtVKgtb0%3D
14. JS Koh SK Goh MA Png EB Kwek TS Howe 2010 Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma 24 75 81 20101130 10.1097/BOT.0b013e3181b6499b
15. J Schilcher P Aspenberg 2009 Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate Acta Orthop 80 413 415 19568963 10.3109/17453670903139914
16. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 1304 1306 18354114 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D (Pubitemid 351439247)
17. MP Somford FW Draijer BJW Thomassen PM Chavassieux G Boivin SE Papapoulus 2009 Clinical vignette. Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility J Bone Miner Res 24 1736 1740 19419297 10.1359/jbmr.090408
18. BM Ingle SM Hay HM Bottjer R Eastell 1999 Changes in bone mass and bone turnover following distal forearm fracture Osteoporosis Int 10 399 407 10.1007/s001980050246 1:STN:280:DC%2BD3c7ht1OjsA%3D%3D
19. M Visekruna D Wilson FE McKiernan 2008 Severely suppressed bone turnover and atypical skeletal fragility J Clin Endocrinol Metab 93 2948 2952 18522980 10.1210/jc.2007-2803 1:CAS:528:DC%2BD1cXpvVOmurg%3D
20. JA Kanis H Johansson A Oden O Johnell C de Laet LJ Melton III A Tenenhouse J Reeve AJ Silman HAP Pols JA Eisman EV McCloskey D Mellstrom 2004 A meta-analysis of prior corticosteroid use and fracture risk J Bone Miner Res 19 893 899 15125788 10.1359/JBMR.040134 (Pubitemid 41103445)
21. P Aspenberg 2008 Bisphosphonate-induced fractures: nature strikes back? Acta Orthop 79 459 460 18766476 10.1080/17453670710015427